4-hydroxy-3-methoxycinnamaldehyde downregulated T cell proliferation and differentiation into Th1 and Th2 cells by inhibiting T-bet and GATA3, respectively, and could ameliorate the symptoms of AD in mice models [226]. Here, GATA3 is linked to Alzheimer disease.